Connection

Andrew Kraft to Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Precursor T-Cell Lymphoblastic Leukemia-Lymphoma.
Andrew Kraft
Connection Strength
2.023
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  1. "Root"ing for successful T-ALL treatment. Blood. 2021 05 06; 137(18):2422-2423.
    View in: PubMed
    Score: 0.755
  2. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 2017 May 02; 8(18):30199-30216.
    View in: PubMed
    Score: 0.572
  3. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood. 2010 Jan 28; 115(4):824-33.
    View in: PubMed
    Score: 0.341
  4. PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis. Mol Cancer Ther. 2020 09; 19(9):1809-1821.
    View in: PubMed
    Score: 0.179
  5. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth. Mol Oncol. 2020 05; 14(5):974-990.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.